Published in Neoplasia on November 05, 2001
The functional differences between pro-survival and pro-apoptotic B cell lymphoma 2 (Bcl-2) proteins depend on structural differences in their Bcl-2 homology 3 (BH3) domains. J Biol Chem (2014) 0.84
Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis. J Biol Chem (2016) 0.78
Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells. J Biol Chem (2015) 0.76
Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia. J Neurosci (2012) 0.76
Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol (1997) 9.18
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A (1994) 8.13
Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A (1998) 6.69
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (1994) 6.69
Bcl-2 family proteins. Oncogene (1998) 3.56
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol (2001) 3.03
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol (2001) 2.43
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol Cell Biol (1997) 2.15
harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J (1997) 1.97
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol (1997) 1.75
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS (1994) 1.68
Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood (1997) 1.54
Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). J Biol Chem (1996) 1.35
Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med (1985) 1.28
A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci U S A (1995) 1.25
Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J Immunol (1994) 1.25
Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech Dev (1996) 1.20
A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity (1997) 1.19
Functional dissection of the human Bc12 protein: sequence requirements for inhibition of apoptosis. Mol Cell Biol (1996) 1.16
Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res (1995) 1.07
Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest (1997) 1.02
Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol (1993) 0.99
Kaposi's sarcoma tumor cells preferentially express Bcl-xL. Am J Pathol (1996) 0.96
Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res (1997) 0.92
Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ (1997) 0.90
Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol (1996) 0.90
Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells. Cancer Res (1996) 0.88
The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L). Mol Cell Biol (1999) 0.86
bcl-X(S)-induced cell death in 3T3 cells does not require or induce caspase activation. Cancer Res (1999) 0.79
Cultured Kaposi's sarcoma tumor cells fail to stimulate T cell proliferation. Clin Immunol Immunopathol (1996) 0.77
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (1990) 14.46
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (1997) 9.58
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity (1999) 7.78
A topological Dirac insulator in a quantum spin Hall phase. Nature (2008) 7.44
Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem (1999) 5.66
A tunable topological insulator in the spin helical Dirac transport regime. Nature (2009) 4.98
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med (1997) 3.90
Keratinocytes as initiators of inflammation. Lancet (1991) 3.68
Observation of unconventional quantum spin textures in topological insulators. Science (2009) 3.58
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem (2000) 3.23
Caspases: the proteases of the apoptotic pathway. Oncogene (1998) 3.11
Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci U S A (1994) 2.91
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut (2003) 2.74
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
Dermal injection of immunocytes induces psoriasis. J Clin Invest (1996) 2.64
Interaction and regulation of subcellular localization of CED-4 by CED-9. Science (1997) 2.58
Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol (1993) 2.55
CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol (1993) 2.54
Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J (1999) 2.45
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res (1997) 2.32
Observation of time-reversal-protected single-dirac-cone topological-insulator states in Bi2Te3 and Sb2Te3. Phys Rev Lett (2009) 2.22
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J (1994) 2.16
NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets (2006) 2.14
The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04
Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol (1993) 2.04
Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A (1998) 2.04
Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol (1989) 1.96
The cytokine network in psoriasis. Arch Dermatol (1991) 1.85
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol (1997) 1.75
The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene (2001) 1.74
Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol (1994) 1.73
Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest (1994) 1.71
Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis (1997) 1.70
A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem (1993) 1.69
Keratinocytes: key immunocytes of the integument. Am J Pathol (1993) 1.69
Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood (1996) 1.68
Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem (1999) 1.64
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol (1994) 1.63
Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol (1989) 1.60
Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol (1984) 1.60
Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol (1998) 1.59
bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation. J Immunol (1993) 1.57
Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood (1997) 1.54
Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest (1990) 1.54
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol (2005) 1.53
Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. J Biol Chem (1996) 1.53
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene (2006) 1.53
Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet (1992) 1.52
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am J Pathol (1989) 1.47
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol (1995) 1.42
Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol (1993) 1.42
Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst (1989) 1.42
Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene (2008) 1.40
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. Lab Invest (1984) 1.38
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ (2002) 1.35
Thrombospondin-induced adhesion of human keratinocytes. J Clin Invest (1988) 1.33
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 1.33
Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci U S A (1994) 1.33
Interaction and regulation of the Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9. J Biol Chem (1997) 1.33
CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis (1997) 1.32
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res (1994) 1.32
Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc Natl Acad Sci U S A (1994) 1.31
A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J (1998) 1.31
Observation of a topological crystalline insulator phase and topological phase transition in Pb(1-x)Sn(x)Te. Nat Commun (2012) 1.30
Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol (1986) 1.30
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res (1995) 1.30
Elevated blood pressure in subjects with lipodystrophy. AIDS (2001) 1.30
Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol (2000) 1.29
Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol (1995) 1.27
What is the 'true' function of skin? Exp Dermatol (2002) 1.26
A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci U S A (1995) 1.25
Fermi surface topology and low-lying quasiparticle dynamics of parent Fe1+xTe/Se superconductor. Phys Rev Lett (2009) 1.25
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev (1998) 1.24
Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol (1991) 1.24
Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol (1995) 1.23
Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev (1999) 1.23
v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene (1994) 1.23
Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol (1997) 1.23
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res (2001) 1.22
Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem (1999) 1.22
Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech Dev (1996) 1.20
c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A (1994) 1.19
Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J Immunol (1996) 1.18
Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol (1991) 1.14